SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019937
Filing Date
2018-08-07
Accepted
2018-08-07 16:14:57
Documents
58
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-10q_20180630.htm 10-Q 2860441
2 EX-10.6 fgen-ex106_71.htm EX-10.6 24213
3 EX-10.7 fgen-ex107_69.htm EX-10.7 8663
4 EX-10.8 fgen-ex108_70.htm EX-10.8 9056
5 EX-31.1 fgen-ex311_6.htm EX-31.1 8313
6 EX-31.2 fgen-ex312_8.htm EX-31.2 8351
7 EX-32.1 fgen-ex321_7.htm EX-32.1 7835
  Complete submission text file 0001564590-18-019937.txt   8836631

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT fgen-20180630.xml EX-101.INS 2138938
9 XBRL TAXONOMY EXTENSION SCHEMA fgen-20180630.xsd EX-101.SCH 42554
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fgen-20180630_cal.xml EX-101.CAL 49045
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fgen-20180630_def.xml EX-101.DEF 172994
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20180630_lab.xml EX-101.LAB 314816
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20180630_pre.xml EX-101.PRE 284919
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 18998128
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences